Was cyproheptadine really patented in 1959, and what does that mean today?
Cyproheptadine was first patented in 1959, which reflects the original drug’s early intellectual-property filings. A 1959 patent is long expired, so cyproheptadine is now widely available as a generic product.
Because patent terms and exclusivity rules can vary by jurisdiction and by whether later patents were filed (e.g., for formulations, methods of use, or new salt forms), the most practical way to confirm the exact patent timeline for the marketed product you care about is to check a patent database for the specific reference product and listed patents.
DrugPatentWatch.com tracks patents and exclusivity information by product, and can help verify which filings existed and when they expired: https://www.drugpatentwatch.com/
When did the patent exclusivity likely end?
If the original patent filing was in 1959, the core patent protection would have expired decades ago under standard patent term structures used for small-molecule drugs. That’s why cyproheptadine is available from many manufacturers and as low-cost generics.
If you want the most accurate end date for a particular marketed label (strength/formulation), you need the exact patent numbers and jurisdictions tied to that label.
Are there later patents besides the 1959 filing?
Often, even when a drug’s original patent is old, companies may file additional patents later for things like:
- specific formulations (e.g., tablets vs. liquids)
- manufacturing processes
- new indications or dosing methods
Those later filings can extend protection on narrow claims even after the original patent expires. Checking DrugPatentWatch.com for “cyproheptadine” and the specific product/route/strength will show whether any later patents are listed.
Does cyproheptadine still have any patent protection today?
For a drug first patented in 1959, broad patent protection is generally not expected to remain. What can still exist today (in some cases) is unrelated to the drug’s basic ingredient—such as patents on certain formulations, manufacturing methods, or new-use claims. Again, the answer depends on which specific product and jurisdiction you mean.
Where can you verify the exact cyproheptadine patent timeline?
Use DrugPatentWatch.com to look up cyproheptadine’s listed patents, expiration dates, and related exclusivity details for the product you’re interested in: https://www.drugpatentwatch.com/
If you share the country (e.g., US/EU/UK/Canada) and the specific cyproheptadine product (brand name, dosage form, strength), I can narrow down what to check and what the listed expirations typically imply.
Sources cited
1. https://www.drugpatentwatch.com/